Skip to content

Breakout Investor

Becoming A Better Investor

Pharmeasy IPO

pharmeasy valuation: Pharmeasy eyes IPO at $3 billion valuation, buys rival Medlife

pharmeasy valuation: Pharmeasy eyes IPO at $3 billion valuation, buys rival Medlife

May 26, 2021

« Previous Page

Breakout Investor © 2024. All Rights Reserved.